Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Grant of Options

30th Mar 2020 09:37

RNS Number : 0195I
Cello Health PLC
30 March 2020
 

30 March 2020

Cello Health plc

("Cello" or "the Company")

Grant of Options

Cello Health plc (AIM: CLL), the global healthcare-focused advisory group announces that today it has granted 2,000,000 options over ordinary shares of 10 pence each in the Company ("Ordinary Shares") to certain directors and employees (the "Options"). Of these, 1,510,000 Options have been issued under the Company's Performance Share Plan Scheme 2010 with an exercise price of 10 pence each. The balance, being 490,000 Options have been issued under the Company's Unapproved Option Plan 2010 and have an exercise price of 108 pence each (being the mid-market closing price on 27 March 2020.

1,450,000 Options were granted to persons discharging managerial responsibilities ("PDMR"), the details of which are set out below:

 

PDMR

 

Existing Options held

New PSP Options granted

Resultant Options

held

Mark Scott

275,000

495,000

770,000

Stephen Highley

140,000

265,000

405,000

Mark Bentley

140,000

250,000

390,000

Julia Ralston

378,000

200,000*

578,000

Andy Brown

45,000

80,000

125,000

Jane Shirley

125,000

80,000

205,000

Jon Bircher

199,608

80,000

279,608

 

*Granted under the Unapproved Option Plan

Further details of the Company's PSP Option Scheme 2010 and Unapproved Option Plan 2010 are set out in the 2018 Annual Report, which can be found on the Company's website: https://www.cellohealth.com/. All options vest over a period of three years, subject to a total shareholder return test against a basket of 11 comparable listed companies.

The Company last granted options to employees on 29 September 2017. The current 2010 schemes expire in May 2020 and therefore this is the last grant that will be made under them.

 

Enquiries

Cello Health

020 7812 8460

Mark Scott, Chief Executive

 

Mark Bentley, Group Finance Director

 

 

 

Cenkos Securities

020 7397 8900

Giles Balleny

 

Harry Hargreaves

 

 

 

Buchanan

020 7466 5000

Mark Court

 

Jamie Hooper

 

Charlotte Slater

 

This notification relates to a transaction notified in accordance with the Market Abuse Regulation, further details below:

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Scott

2

Reason for the notification

a)

Position/status

Chief Executive Officer, PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 495,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Highley

2

Reason for the notification

a)

Position/status

Chief Operating Officer PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 265,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Group Finance Director, PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 250,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Julia Ralston

2

Reason for the notification

a)

Position/status

Chief Executive Officer, Cello Health US PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 200,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andy Brown

2

Reason for the notification

a)

Position/status

Deputy Group Finance Director - PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 80,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

CEO Cello Health Europe PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 80,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jon Bircher

2

Reason for the notification

a)

Position/status

Chief Commercial Officer - Cello Health PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cello Health plc

b)

Legal entity identifier code

2138004TZYGZLWQP7N64

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

b)

Identification Code

ISIN of Ordinary Shares: GB00B0310763

c)

Nature of the transaction

Grant of options over Ordinary Shares of 10 pence each

d)

Currency

GBP - British pound

e)

Price(s) and Volume(s)

Options over 80,000 Ordinary shares

f)

Aggregated information

- Price

- Volume

- Total

N/A

g)

Date of transaction

30 March 2020

h)

Place of transaction

Off market

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKKKBNFBKKQNN

Related Shares:

CLL.L
FTSE 100 Latest
Value8,809.74
Change53.53